Zhong Ji Longevity Science Group Limited (HK:0767)
:0767
Want to see HK:0767 full AI Analyst Report?
0767 Stock Chart & Stats
HK$0.51
-HK$0.01(-5.85%)
At close: 4:00 PM EST
HK$0.51
-HK$0.01(-5.85%)
Day’s Range― - ―
52-Week RangeHK$0.32 - HK$0.72
Previous CloseN/A
Volume650.00K
Average Volume (3M)487.89K
Market Cap
HK$276.94M
Enterprise ValueHK$223.20M
Total Cash (Recent Filing)HK$24.30M
Total Debt (Recent Filing)HK$5.57M
Price to Earnings (P/E)―
Beta-0.11
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding636,654,300
10 Day Avg. Volume325,210
30 Day Avg. Volume487,892
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)0.75
Price to Sales (P/S)1.80
P/FCF Ratio-12.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Financial LeverageVery low debt relative to equity materially reduces refinancing and solvency risk, giving the company durable financial flexibility. Over the next several months this conservative capital structure limits bankruptcy risk and preserves optionality to fund recovery or strategic initiatives without heavy interest burdens.
Sizeable Equity BaseA sizeable, stable equity base provides a cushion against losses and supports ongoing operations while management works to restore profitability. This capital buffer sustains solvency and the ability to absorb short-term shocks, making recovery less dependent on immediate external financing.
Prior Cash Generation CapabilityHistorical positive operating and free cash flow in 2023 demonstrates the business can generate cash under better conditions. That track record indicates operational levers exist to restore cash generation, which is important for medium-term viability and reduces reliance on permanent capital raises.
Bears Say
Sustained LossesMaterial swing from a small profit in 2023 to sustained, sizable losses in 2024–2025 indicates structural profitability issues. Persistently negative margins erode equity and hinder reinvestment, making multi-quarter recovery harder without meaningful business model changes or cost restructuring.
Negative Cash GenerationConsecutive years of negative operating and free cash flow create ongoing liquidity pressure and increase dependence on reserves or external funding. Over months this undermines the firm's ability to invest, service obligations, and execute strategic initiatives without dilutive or costly financing.
Compressed Margins & Volatile RevenueSharp gross-margin compression and recent revenue decline signal weakening unit economics and possible adverse mix or pricing pressure. Structural margin deterioration reduces profit leverage on revenue, making it harder to achieve sustainable profitability even if top-line stabilizes.
Zhong Ji Longevity Science Group Limited News
0767 FAQ
What was Zhong Ji Longevity Science Group Limited’s price range in the past 12 months?
Zhong Ji Longevity Science Group Limited lowest stock price was HK$0.32 and its highest was HK$0.72 in the past 12 months.
What is Zhong Ji Longevity Science Group Limited’s market cap?
Zhong Ji Longevity Science Group Limited’s market cap is HK$276.94M.
When is Zhong Ji Longevity Science Group Limited’s upcoming earnings report date?
Zhong Ji Longevity Science Group Limited’s upcoming earnings report date is Aug 31, 2026 which is in 77 days.
How were Zhong Ji Longevity Science Group Limited’s earnings last quarter?
Zhong Ji Longevity Science Group Limited released its earnings results on Mar 26, 2026. The company reported -HK$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.007.
Is Zhong Ji Longevity Science Group Limited overvalued?
According to Wall Street analysts Zhong Ji Longevity Science Group Limited’s price is currently Overvalued.
Does Zhong Ji Longevity Science Group Limited pay dividends?
Zhong Ji Longevity Science Group Limited does not currently pay dividends.
What is Zhong Ji Longevity Science Group Limited’s EPS estimate?
Zhong Ji Longevity Science Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zhong Ji Longevity Science Group Limited have?
Zhong Ji Longevity Science Group Limited has 636,654,300 shares outstanding.
What happened to Zhong Ji Longevity Science Group Limited’s price movement after its last earnings report?
Zhong Ji Longevity Science Group Limited reported an EPS of -HK$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1%.
Which hedge fund is a major shareholder of Zhong Ji Longevity Science Group Limited?
Currently, no hedge funds are holding shares in HK:0767
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zhong Ji Longevity Science Group Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
120.33%
12-Months-Change
Fundamentals
Return on Equity
-4.17%
Trailing 12-Months
Asset Growth
-4.89%
Trailing 12-Months
Company Description
Zhong Ji Longevity Science Group Limited
Zhong Ji Longevity Science Group Limited operates as an investment holding entity, engaging in a broad spectrum of commercial endeavors. Its operations include providing money lending solutions across Hong Kong and Mainland China. The company's healthcare division delivers diagnostic advisory services, medical examination and testing, and the supply of health-related supplements. Furthermore, Zhong Ji Longevity is involved in holding equity stakes, investing in both short and long-term financial instruments, offering financial and investment advisory, and property acquisition. It also extends health advisory services and deals in medical commodities. Founded in 1994, the company was formerly known as Asia Pacific Silk Road Investment Company Limited before rebranding to its current name in March 2021. Its main office is situated in Causeway Bay, Hong Kong.
Technical Analysis
Zhaobangji Properties Holdings Limited
―
China Properties Investment Holdings Limited
―
Hao Wen Holdings Ltd.
―
Ziyuanyuan Holdings Group Ltd.
―
Baiying Holdings Group Ltd.
―